Physician profile
Gordon Wong
NPI 1811072861
$5,053.51
in general payments reported to CMS, 2019-2025
20 companies · $75.12 in 2025
The $75.12 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $111 · 2021: $744 · 2022: $563 · 2023: $2,008 · 2024: $981 · 2025: $75.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $2,502.33 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $846.95 | 2021-2023 | Opticross, Avvigo Guidance System, Rotapro |
| Abbott Laboratories | $610.43 | 2021-2024 | Xience Skypoint, Dragonfly Opstar, Pressurewire |
| Glaxosmithkline, LLC. | $153.89 | 2019-2020 | |
| Philips North America LLC | $140.91 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.33 | 2019-2021 | |
| Chiesi USA, INC. | $119.49 | 2021-2023 | Kengreal |
| Regeneron Healthcare Solutions, INC. | $110.50 | 2019 | |
| Grifols USA, LLC | $69.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $65.91 | 2019-2020 | |
| Abiomed | $50.62 | 2021-2022 | |
| Genzyme Corporation | $41.77 | 2019-2021 | |
| Esperion Therapeutics, INC. | $40.82 | 2025 | Nexletol |
| Paratek Pharmaceuticals, INC. | $38.34 | 2019 | |
| Mylan Specialty L.P. | $36.71 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $25.04 | 2021 | |
| Theratechnologies INC. | $22.09 | 2019 | |
| Allergan, INC. | $20.54 | 2020 | |
| Pfizer INC. | $19.34 | 2019 | |
| Shire North American Group INC | $17.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.